Management of prolonged cytopenia following CAR T-cell therapy

Bone Marrow Transplant. 2022 Dec;57(12):1839-1841. doi: 10.1038/s41409-022-01771-x. Epub 2022 Sep 21.

Magdalena Corona^{1

2}, Roni Shouval^{1

3}, Ana Alarcón^{1

4}, Jessica Flynn⁵, Sean Devlin⁵, Connie Batlevi^{3

6}, Simon Mantha⁷, Maria Lia Palomba^{3

6}, Michael Scordo^{1

3}, Gunjan Shah^{1

3}, Craig Sauter⁸, Miguel-Ángel Perales^{1

3}, Parastoo B Dahi^{9

10}

¹ Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Hematology and Hemotherapy Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.
³ Weill Cornell Medical College, New York, NY, USA.
⁴ Hematology and Hemotherapy Service, Hospital Universitario Gregorio Marañón, Madrid, Spain.
⁵ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁸ Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
⁹ Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. dahip@mskcc.org.
¹⁰ Weill Cornell Medical College, New York, NY, USA. dahip@mskcc.org.

No abstract available

Publication types